Jingtian Mu
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 2
- Oncology top 10%
- Cancer Cells and Metastasis 2
-
- Metabolomics and Mass Spectrometry Studies 1
- Extracellular vesicles in disease 1
- Fibroblast Growth Factor Research 1
-
- Contact Dermatitis and Allergies 1
-
- Autophagy in Disease and Therapy 1
-
- Cancer Research and Treatments 1
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- International Journal of Molecular Sciences (1 paper)Signal Transduction and Targeted Therapy (1 paper)Archives of Oral Biology (1 paper)
- Partner nations
- China
In The Last Decade
Jingtian Mu
7 papers receiving 539 citations
Hit Papers
Peers
Comparison fields: 5 of 66
- Cancer Research 168
- Oncology 273
- Immunology 142
- Molecular Biology 248
- Cell Biology 43
Countries citing papers authored by Jingtian Mu
This map shows the geographic impact of Jingtian Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingtian Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingtian Mu more than expected).
Fields of papers citing papers by Jingtian Mu
This network shows the impact of papers produced by Jingtian Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingtian Mu. The network helps show where Jingtian Mu may publish in the future.
Co-authorship network
The 14 scholars most cited alongside Jingtian Mu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 16 | |
| 5 | 2022 | 19 | |
| 6 | 2022 | 2 | |
| 7 | Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancerbreakdown → | 2021 | 501 |
| 8 | 2021 | 3 |
About Jingtian Mu
Jingtian Mu is a scholar working on Cancer Research, Otorhinolaryngology and Periodontics, having authored 8 papers that have together received 543 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (2 papers), Cancer Cells and Metastasis (2 papers), Contact Dermatitis and Allergies (1 paper), Autophagy in Disease and Therapy (1 paper), Metabolomics and Mass Spectrometry Studies (1 paper), Extracellular vesicles in disease (1 paper), Cancer Research and Treatments (1 paper) and Fibroblast Growth Factor Research (1 paper). The work is most often cited by research in Cancer Research (168 citations), Oncology (273 citations) and Immunology (142 citations). Jingtian Mu has collaborated with scholars based in China. Frequent co-authors include Hongmei Zhou, Fanglong Wu, Jin Yang, Qingxiang Zeng, Junjiang Liu, Ye Wang, Xiaowei Liu, Shengtao Gao, Qinghong Gao and Xin He. Their work appears in journals such as International Journal of Molecular Sciences, Signal Transduction and Targeted Therapy and Archives of Oral Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.